Menu

Products

ArcTV® Transvaginal Sling System

UroCure’s ArcTV sling is a medical device designed to mitigate the effects of stress urinary incontinence in women. Developed in collaboration with leading surgeons, the new ArcTV sling incorporates features of a popular retropubic sling patented by Dr. David Staskin for American Medical Systems (AMS) in the early 2000s, eight enhancements such as a stabilizing suture and a blue knitted mesh with softened, laser-cut edges. The ArcTV sling is engineered for the safe and accurate placement of a midurethral sling by the vaginal route. Every aspect of the ArcTV sling has been carefully considered for how it serves both doctor and patient.

If you would like more information, please call Customer Service at 612.466.0117 or email us at customerservice@urocure.com. Click below for more details.


ArcTV sling

  • Equi-cutTM sling with precision laser-cut edges
  • Patented absorbable stabilizing suture
UroCure Suture

Learn the benefits of the stabilizing suture in the sling


  • Designed to maintain sling integrity under tension

ArcTV sling in sheath

  • Soft, easily-removable sheaths
  • Atraumatic tapered sheaths
UroCure Sheath

To see our best-in-class sheath


Handle and needle assembly

  • Compact design with 4mm diameter needle
UroCure Handle

Learn about our superior handle and needle


CAUTION: US Federal law restricts this device to sale by or on the order of a physician. This device is intended for use only by physicians with adequate training and experience in the use of polypropylene slings for stress urinary incontinence.

The following adverse events have been reported due to polypropylene mid-urethral sling placement, but are not limited to: Complete failure of the procedure, including worsening of incontinence; partial failure resulting in mild to moderate incontinence; de novo, persistent or worsening overactive bladder and/or detrusor overactivity symptoms, with or without urge incontinence; temporary or permanent lower urinary tract obstruction and retention; tissue responses to the sling implant include; erosion, exposure, extrusion of the mesh through the vaginal or urethral mucosa, bladder wall or other surrounding tissue and/or other organs; scarring / scar contracture / mesh contracture / tissue contraction of vagina or surrounding tissues; device migration; fistula formation and inflammation; dehiscence of vaginal incision; vaginal discharge; an acute or chronic foreign body inflammatory response or infection, which may result in systemic symptoms, pain, damage to adjacent structures, scarring and adhesion; local irritation at the wound site and/or a foreign body response, like all foreign bodies, the polypropylene sling may potentiate an existing infection; allergic reaction to the polypropylene sling; edema and erythema at the wound site; infection (superficial, abscess, systemic sepsis); bleeding (routine surgical, hematoma, hemorrhage); bruising, bleeding, hematoma formation (vaginal, retropubic, abdominal, or thigh); perforation or laceration of vessels, nerves, bladder, urethra or bowel; pain (local or regional) that may be acute or chronic; pain, ongoing pain (pelvic, bladder, vaginal, groin, thigh, suprapubic, dyspareunia, with voiding); severe chronic pain; vaginal shortening or stenosis, which may result in dyspareunia and/or sexual dysfunction; loss of sexual function, temporary or permanent, secondary to pain and/or mesh contracture, tissue contracture or scarring; including inability to have intercourse which may not resolve; pain or discomfort to the patient’s partner during intercourse caused by exposed mesh. The occurrence of adverse events from this procedure may require additional surgical interventions, including removal of the entire sling. The adverse events may persist as a permanent condition after the surgical intervention(s) or treatment(s). Removal of a portion of or the entire sling and/or attempts to correct the sling or procedure related adverse events may involve multiple surgeries. Complete removal of sling may not be possible and additional surgeries may not always fully correct the adverse events and/or associated symptoms. These additional surgeries are associated with their own unique adverse events.

For further information on indications, contraindications, warnings and precautions, and adverse events refer to the product instructions for use at www.urocure.com/ifu.


Product Brochure

Product Brochure

Read about what makes UroCure’s ArcTV Sling System the treatment of choice for physicians performing surgery to address stress urinary incontinence in women.

Testimonials

“The sheath surrounding the sling is soft and supple and that helps with sheath removal. In my opinion, it’s the best on the market.”

“The new Patient Device Card is a welcome innovation: patients appreciate knowing what device is going into their bodies.”

“The Stabilizing Suture is a unique feature. It gives me added confidence that the sling will maintain its shape under the urethra.”

“UroCure’s partnership with AUGS and its ACQUIRE Registry is leading the way in how companies should launch new medical device products for women. Data collected in this registry will ensure product and procedure accountability as well as contribute to better patient outcomes.”